National

Baby killed, father hurt in Vancouver crash

Darpan News Desk The Canadian Press, 07 Jul, 2021 09:43 AM

An 11-month-old has been killed and the infant's father injured after they were hit by one of two vehicles that collided in downtown Vancouver.

#ICYMI: Here’s the VPD livestream of today’s new conference in relation to a car cash which claimed the life of an eleven month old child and injured her 31-year-old father. https://t.co/GJGsj9Sz6g
— Vancouver Police (@VancouverPD) July 7, 2021

Police say the pedestrians were hit as an SUV and a sports car collided Tuesday night.

The condition of the 31-year-old man was not available.

Const. Tania Visintin describes one of the two drivers as a suspect and says he was also injured and treated in hospital.

The cause of the crash is under investigation.

Visintin says more details could be released later.

Prev Next

MORE National ARTICLES

COVID-19 vaccines making difference in B.C.: Henry

Government data is showing reduced community transmissions as more people receive their first doses of vaccine, provincial health officer Dr. Bonnie Henry said Thursday.

COVID-19 vaccines making difference in B.C.: Henry

Action needed on hate crimes in Vancouver: leaders

The comments came Thursday during a roundtable discussion on anti-Asian hate crimes hosted by the Vancouver Police Board.

Action needed on hate crimes in Vancouver: leaders

5 COVID19 deaths for Thursday

There are 5 new deaths. One person in 60s, everyone else older than 70. There have been 1,632 total COVID deaths in BC.

5 COVID19 deaths for Thursday

Partial brick of suspected cocaine seized by Surrey Gang Enforcement Team

This amount of cocaine when packaged for streel level sale is 1,225 doses, the equivalent of 25 busloads of people.

Partial brick of suspected cocaine seized by Surrey Gang Enforcement Team

Canadian vaccine maker touts promising results

Calgary-based Providence Therapeutics says its vaccine produced no serious adverse events and developed good antibodies against COVID-19 that "compare favourably" with the two mRNA vaccines already on the market from Pfizer and Moderna.